论文部分内容阅读
目的:调查吸入给药制剂的使用情况,为临床合理用药提供参考。方法:回顾性调查125家医院2011~2015年吸入给药制剂的销售情况,收集各医院西药销售总额,吸入给药制剂销售总额,各制剂销售金额等内容进行计算分析。结果:吸入给药制剂销售金额逐年上升,进口药品占市场主导地位,四种剂型中雾化液销售占比最高,三级医院雾化液销售占比为42.75%,二级医院为49.22%。糖皮质激素类药物是5种不同活性成分类别里销售占比最高的,三级医院糖皮质激素类药物销售占比为45.48%,二级医院为47.61%。结论:吸入给药制剂的应用情况基本合理,在呼吸系统疾病治疗中应用尚少,使用情况与医院规模及所在区域有关。
Objective: To investigate the use of inhaled drug preparation and provide reference for clinical rational drug use. Methods: A retrospective survey of 125 hospitals from 2011 to 2015 inhaled drug delivery, collect the total sales of Western medicine hospitals, the total sales of inhaled drug formulations, the amount of sales of various preparations for calculation and analysis. Results: The sales volume of inhaled drug preparation increased year by year with imported medicine taking the leading position in the market. The sales of atomized liquid among the four dosage forms accounted for the highest proportion. The sales of atomized liquid in tertiary hospital accounted for 42.75% and the secondary hospital was 49.22%. Glucocorticoid drugs accounted for the highest percentage of sales in five different active ingredients categories, with 45.48% of tertiary hospitals selling glucocorticoid drugs and 47.61% of secondary hospitals. Conclusion: The application of inhaled drug delivery system is basically reasonable, and its application in the treatment of respiratory diseases is still rare. The usage is related to the size of the hospital and the area in which it is located.